Fidson Healthcare plc is reporting 790% profit margin to 7NGN30.2 million for the nine months ended in 2017 compared to NGN82.0 million reported in the same period in the financial year 2016.
The company ended the period with NGN10.3 billion revenue in contrast to 4NGN.5 billion it ended the last year with while gross profit increased to NGN5.2 billion against NGN2.3 billion in the year before.
The company’s operating profit for 2017 increased to NGN1.6 billion in contrast to NGN581.6 million in the fiscal year 2016.
The company’s total assets was NGN17.4 billion in 2016 compared to NGN16.6 billion acquired in the year 2016 while total liabilities was NGN10.2 billion versus NGN10.0 billion in the year before.
Fidson Healthcare Plc is a leading pharmaceutical manufacturing company in Nigeria. Founded in 1995, we have relentlessly pursued our goal of becoming a leading player in the pharmaceutical landscape in Nigeria. Ever since, we have built and cultured an organizational framework that has steadily helped us gain ascendancy in the industry.
We have crafted the pharmaceutical architecture of the industry over the years of our existence, playing very defining roles in the emergence of the new generation of industry players. Innovation, Excellence, Passion, Integrity and Ownership…are five core values that form the substructure on which we have built a world-class company that has earned the respect and admiration of even the fiercest of our competitors.